Evidence map›Paper›PMID 20605781›Full record

ArticleThe Journal of biological chemistry2010

mTORC1 links protein quality and quantity control by sensing chaperone availability.

Shu-Bing Qian, Xingqian Zhang, Jun Sun, Jack R Bennink, Jonathan W Yewdell, Cam Patterson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The role of mTOR in age-related diseases.Journal of enzyme inhibition and medicinal chemistry · 2021
    Review
  7. The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer.Journal of experimental & clinical cancer research : CR · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases.International journal of molecular sciences · 2018
    Review
  13. Article
  14. Article
  15. mTORC1 senses stresses: Coupling stress to proteostasis.BioEssays : news and reviews in molecular, cellular and developmental biology · 2017
    Review
  16. Review
  17. Article
  18. HSF1: Guardian of Proteostasis in Cancer.Trends in cell biology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Shu-Bing QianDivision of Nutritional Sciences, Cornell University, Ithaca, New York 14853. Electronic address: sq38@cornell.edu.
Xingqian ZhangDivision of Nutritional Sciences, Cornell University, Ithaca, New York 14853.
Jun SunDivision of Nutritional Sciences, Cornell University, Ithaca, New York 14853.
Jack R BenninkLaboratory of Viral Diseases, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
Jonathan W YewdellLaboratory of Viral Diseases, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
Cam PattersonMcAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina 27599. Electronic address: cpatters@med.unc.edu.
Cornell University · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USUniversity of North Carolina at Chapel Hill · US

Funding

UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN M. SMITH · 1999 to 2026
$31.6M
OXIDATIVE STRESS AND VASCULAR AGINGP01AG024282 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CLEMMONS, DAVID ROBERT · 2004 to 2008
$7.4M
CHIP: A link between the chaperone &proteasome systemsR01GM061728 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SCHISLER, JONATHAN C. · 2001 to 2013
$3.4M
Proteolytic Generation Of Antigenic PeptidesZIAAI000658 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BENNINK, JACK R · 2009 to 2012
$1.9M
NIA NIH HHS AG024282NIA NIH HHS P01 AG024282NIDDK NIH HHS DK056350NIDDK NIH HHS P30 DK056350NIGMS NIH HHS GM61728NIGMS NIH HHS R01 GM061728
6 · The paper itself

Abstract

Balanced protein synthesis and degradation are crucial for proper cellular function. Protein synthesis is tightly coupled to energy status and nutrient levels by the mammalian target of rapamycin complex 1 (mTORC1). Quality of newly synthesized polypeptides is maintained by the molecular chaperone and ubiquitin-proteasome systems. Little is known about how cells integrate information about the quantity and quality of translational products simultaneously. We demonstrate that cells distinguish moderate reductions in protein quality from severe protein misfolding using molecular chaperones to differentially regulate mTORC1 signaling. Moderate reduction of chaperone availability enhances mTORC1 signaling, whereas stress-induced complete depletion of chaperoning capacity suppresses mTORC1 signaling. Molecular chaperones regulate mTORC1 assembly in coordination with nutrient availability. This mechanism enables mTORC1 to rapidly detect and respond to environmental cues while also sensing intracellular protein misfolding. The tight linkage between protein quality and quantity control provides a plausible mechanism coupling protein misfolding with metabolic dyshomeostasis.

Indexed as

Protein FoldingCell LineHumansMechanistic Target of Rapamycin Complex 1Molecular ChaperonesMultiprotein ComplexesProtein BiosynthesisProteinsSignal TransductionTOR Serine-Threonine KinasesTranscription FactorsMechanistic Target of Rapamycin Complex 1Molecular ChaperonesMultiprotein ComplexesProteinsTOR Serine-Threonine KinasesTranscription Factors

Identifiers

PMID20605781
PMCPMC2930736
OpenAlexW2127646238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.